Clinical trial
Protein Synthesis in the Brain of Patients With Fragile X Syndrome
NCT00362843 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00362843 |
|---|---|
| Title | Protein Synthesis in the Brain of Patients With Fragile X Syndrome |
| Official title | PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects With Fragile X Syndrome |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Fragile X Syndrome, Healthy Volunteers |
| Intervention type | Drug |
| Interventions | [15-O]water |
| Enrollment | 147 |
| Start date | Aug 22, 2006 |
| Primary completion | May 1, 2020 |
| Completion | May 1, 2020 |
| First posted | Aug 10, 2006 |
| Last update posted | Oct 8, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: